AxoGen Inc., a Gainesville, Fla.-based developer of implantable peripheral nerve grafts, has raised $7.75 million in Series B funding. Backers include Accuitive Medical Ventures, Cardinal Partners, De Novo Ventures and Springboard Capital. AxoGen presented at the Southeastern BIO Investor Forum in 2003, 2004, and 2005. www.axogeninc.com